Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention.
Dangas
George
G
Cardiovascular Research Foundation, New York, New York 10022, USA. gdangas@crf.org
Mehran
Roxana
R
Feldman
Dmitriy
D
Stoyioglou
Athanasios
A
Pichard
Augusto D
AD
Kent
Kenneth M
KM
Satler
Lowell F
LF
Fahy
Martin
M
Lansky
Alexandra J
AJ
Stone
Gregg W
GW
Leon
Martin B
MB
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002423:Cause of Death; D003327:Coronary Disease / Q000401:mortality / Q000628:therapy*; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D018487:Ventricular Dysfunction, Left / Q000401:mortality*
D007527:Isoenzymes; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form